Glaxosmithkline Investment
- All
- News
- Videos
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
Sanofi To Invest 400 Million Euros In A mRNA Vaccines Facility
The French drug giant and its British counterpart GlaxoSmithKline surprised investors and customers last year when they announced a one-year delay to the launch of their joint COVID vaccine, based on a more conventional technology.
-
Government Plans To Pull In 324 Companies Including Tesla, Glaxo: Report
Under the plan, the government will create a land bank for ready-to-move-in industrial clusters, offer investment and location-based incentives and rationalize anti-dumping duties.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
UK Drugs Giant GSK Invests 275 Million Pounds Despite Brexit
Drugmaker GlaxoSmithKline on Wednesday revealed plans to invest 275 million pounds into three of its British manufacturing sites, shrugging off Brexit worries.
-
GSK Pharma's Bengaluru Facility to be Operational by 2017
The new site, which represents up to Rs 1,000 crore in investments, will be the first greenfield pharma site GSK has built across the globe over the past 10 years.
-
China Hands GlaxoSmithKline Record $489 Million Fine
China fined GlaxoSmithKline Plc a record 3 billion yuan ($490 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drug maker.
-
GSK to invest $200 million in African factories, R&D
Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds in Africa over the next five years as chronic diseases become more common among the continent's swelling urban middle classes.
-
GlaxoSmithKline's Rs 6,400-crore FDI proposal cleared by investment board: report
The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.
-
GlaxoSmithKline seeks FIPB nod to hike stake in Indian arm: report
The proposal will come up before the meeting of the Foreign Investment Promotion Board (FIPB), headed by Economic Affairs Secretary Arvind Mayaram, on January 10.
-
GSK bets on emerging markets with $1 billion investment in India
With the latest India deal, GSK is set to spend close to $2 billion in roughly a year to increase its holdings in two listed Indian companies, its biggest incremental investment in any country in that period.
-
GlaxoSmithKline to divest $740-million stake in South Africa's Aspen
GlaxoSmithKline said on Tuesday that it planned to reduce its investment in South African drug maker Aspen Pharmacare by one third, although it would retain a board seat and a significant shareholding.
-
GlaxoSmithKline to invest Rs 864 crore in India to set up pharma unit
Global pharmaceutical major GlaxoSmithKline (GSK) on Thursday announced a Rs 864 crore investment in India to set up a medicine manufacturing unit.
-
FIPB clears 7 pharma FDI proposals, defers 3
The proposals which were discussed in the meeting today include that of Singapore's GlaxoSmithKline Pte Ltd, USA's Mylan Inc, Mauritius-based Castleton Investment Ltd, Mumbai-based Ferring Therapeutics and Hyderabad-based Verdant Life Sciences.
-
Sensex, Nifty end flat as Parliament logjam continues
As the stalemate continued in the Winter Session of Parliament for the second consecutive day, market sentiment took a hit and closed marginally lower. Investors are nervous about the ability of Parliament to pass key reform bills related to foreign direct investment in insurance, pending and retail sectors.
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
Sanofi To Invest 400 Million Euros In A mRNA Vaccines Facility
The French drug giant and its British counterpart GlaxoSmithKline surprised investors and customers last year when they announced a one-year delay to the launch of their joint COVID vaccine, based on a more conventional technology.
-
Government Plans To Pull In 324 Companies Including Tesla, Glaxo: Report
Under the plan, the government will create a land bank for ready-to-move-in industrial clusters, offer investment and location-based incentives and rationalize anti-dumping duties.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
UK Drugs Giant GSK Invests 275 Million Pounds Despite Brexit
Drugmaker GlaxoSmithKline on Wednesday revealed plans to invest 275 million pounds into three of its British manufacturing sites, shrugging off Brexit worries.
-
GSK Pharma's Bengaluru Facility to be Operational by 2017
The new site, which represents up to Rs 1,000 crore in investments, will be the first greenfield pharma site GSK has built across the globe over the past 10 years.
-
China Hands GlaxoSmithKline Record $489 Million Fine
China fined GlaxoSmithKline Plc a record 3 billion yuan ($490 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drug maker.
-
GSK to invest $200 million in African factories, R&D
Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds in Africa over the next five years as chronic diseases become more common among the continent's swelling urban middle classes.
-
GlaxoSmithKline's Rs 6,400-crore FDI proposal cleared by investment board: report
The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.
-
GlaxoSmithKline seeks FIPB nod to hike stake in Indian arm: report
The proposal will come up before the meeting of the Foreign Investment Promotion Board (FIPB), headed by Economic Affairs Secretary Arvind Mayaram, on January 10.
-
GSK bets on emerging markets with $1 billion investment in India
With the latest India deal, GSK is set to spend close to $2 billion in roughly a year to increase its holdings in two listed Indian companies, its biggest incremental investment in any country in that period.
-
GlaxoSmithKline to divest $740-million stake in South Africa's Aspen
GlaxoSmithKline said on Tuesday that it planned to reduce its investment in South African drug maker Aspen Pharmacare by one third, although it would retain a board seat and a significant shareholding.
-
GlaxoSmithKline to invest Rs 864 crore in India to set up pharma unit
Global pharmaceutical major GlaxoSmithKline (GSK) on Thursday announced a Rs 864 crore investment in India to set up a medicine manufacturing unit.
-
FIPB clears 7 pharma FDI proposals, defers 3
The proposals which were discussed in the meeting today include that of Singapore's GlaxoSmithKline Pte Ltd, USA's Mylan Inc, Mauritius-based Castleton Investment Ltd, Mumbai-based Ferring Therapeutics and Hyderabad-based Verdant Life Sciences.
-
Sensex, Nifty end flat as Parliament logjam continues
As the stalemate continued in the Winter Session of Parliament for the second consecutive day, market sentiment took a hit and closed marginally lower. Investors are nervous about the ability of Parliament to pass key reform bills related to foreign direct investment in insurance, pending and retail sectors.
